Autologous T Cells Expressing MET scFv CAR (RNA CART-cMET)

NCT03060356 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

77

Enrollment

OTHER

Sponsor class

Stopped Halt in funding

Conditions

Malignant Melanoma
Breast Cancer

Interventions

BIOLOGICAL: T cells modified with RNA anti -cMET CAR

Sponsor

University of Pennsylvania